Assessing Cigna Group: Insights From 8 Financial Analysts
Portfolio Pulse from Benzinga Insights
Eight financial analysts have recently shared their insights on Cigna Group (NYSE:CI), with opinions ranging from bullish to bearish. The average 12-month price target for CI is $348.25, with a high estimate of $372.00 and a low estimate of $327.00, marking a slight increase from the previous average of $347.00. Analyst actions include ratings from 'Buy' to 'Sector Perform' with adjustments to price targets. Cigna, a major player in health insurance and pharmacy benefit management, shows strong market performance with a notable revenue growth rate of 8.46% and impressive profitability metrics such as a net margin of 2.87% and ROE of 3.09%.

February 01, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cigna Group's stock is under the spotlight with mixed analyst ratings and a slight increase in the average 12-month price target to $348.25. The company's strong financial performance, including a revenue growth rate of 8.46% and high profitability metrics, supports a positive outlook.
The mixed analyst ratings reflect a diverse view on Cigna Group's future performance, but the overall positive financial indicators such as revenue growth and profitability metrics suggest a potential upward trend in the short term. The slight increase in the average price target further supports this positive outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100